Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Cross Above 200-Day Moving Average – Here’s What Happened

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)’s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $22.84 and traded as high as $23.84. Fresenius Medical Care AG & Co. KGaA shares last traded at $23.73, with a volume of 490,927 shares trading hands.

Wall Street Analysts Forecast Growth

FMS has been the subject of a number of research analyst reports. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, May 6th. Zacks Research downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 27th. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, May 7th. Citigroup reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, April 24th. Finally, Wall Street Zen cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Four investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Strong Sell” and an average target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Stock Performance

The stock has a market cap of $12.55 billion, a P/E ratio of 12.22, a price-to-earnings-growth ratio of 4.28 and a beta of 0.80. The firm’s 50-day moving average is $22.32 and its two-hundred day moving average is $22.84. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.40.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The company had revenue of $5.34 billion during the quarter. As a group, research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were issued a $0.8716 dividend. This is a boost from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. This represents a yield of 402.0%. The ex-dividend date was Friday, May 22nd. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio is currently 32.11%.

Institutional Trading of Fresenius Medical Care AG & Co. KGaA

Institutional investors and hedge funds have recently made changes to their positions in the stock. AQR Capital Management LLC boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 14.2% during the 1st quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock worth $356,000 after acquiring an additional 1,777 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Fresenius Medical Care AG & Co. KGaA by 160.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock worth $1,075,000 after purchasing an additional 23,163 shares during the last quarter. American Century Companies Inc. lifted its holdings in Fresenius Medical Care AG & Co. KGaA by 21.3% in the 2nd quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock worth $833,000 after purchasing an additional 5,127 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock worth $146,000 after purchasing an additional 896 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its position in Fresenius Medical Care AG & Co. KGaA by 141.8% during the second quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock worth $83,000 after purchasing an additional 1,704 shares during the period. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.